Thursday, March 9, 2017
Corbus to Present Promising Data on Resunab as Systemic Sclerosis Treatment
3/09/2017 11:00:00 PM
No comments
Corbus Pharmaceuticals will present results showing that Resunab (JBT-101), the company’s cannabis-derived treatment for systemic sclerosis (SSc), can trigger specific molecular pathways which resolve inflammation and halt fibrosis.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment